LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
8.55
+0.29 (3.51%)
At close: May 12, 2025, 4:00 PM
8.61
+0.06 (0.70%)
After-hours: May 12, 2025, 7:59 PM EDT
LifeMD Market Cap
LifeMD has a market cap or net worth of $388.58 million as of May 12, 2025. Its market cap has decreased by -13.75% in one year.
Market Cap
388.58M
Enterprise Value
379.28M
1-Year Change
-13.75%
Ranking
Category
Stock Price
$8.55
Market Cap Chart
Since April 1, 2013, LifeMD's market cap has increased from $3.50M to $388.58M, an increase of 11,002.20%. That is a compound annual growth rate of 47.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 375.40M | 75.09% |
| Dec 31, 2024 | 214.40M | -31.89% |
| Dec 29, 2023 | 314.80M | 416.07% |
| Dec 30, 2022 | 61.00M | -48.48% |
| Dec 31, 2021 | 118.40M | -22.11% |
| Dec 31, 2020 | 152.00M | 2,391.80% |
| Dec 31, 2019 | 6.10M | -4.69% |
| Dec 31, 2018 | 6.40M | -57.62% |
| Dec 29, 2017 | 15.10M | 65.93% |
| Dec 30, 2016 | 9.10M | 145.95% |
| Dec 31, 2015 | 3.70M | 19.35% |
| Dec 31, 2014 | 3.10M | -59.21% |
| Dec 31, 2013 | 7.60M | 117.14% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |